171 related articles for article (PubMed ID: 16710316)
1. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
[TBL] [Abstract][Full Text] [Related]
2. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat.
Wolden-Hanson T; Mitton DR; McCants RL; Yellon SM; Wilkinson CW; Matsumoto AM; Rasmussen DD
Endocrinology; 2000 Feb; 141(2):487-97. PubMed ID: 10650927
[TBL] [Abstract][Full Text] [Related]
3. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
[TBL] [Abstract][Full Text] [Related]
4. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
Beebe KL; Block T; Debattista C; Blasey C; Belanoff JK
Behav Brain Res; 2006 Aug; 171(2):225-9. PubMed ID: 16782211
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
Han M; Deng C; Burne TH; Newell KA; Huang XF
Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
[TBL] [Abstract][Full Text] [Related]
7. Visceral and subcutaneous fat in patients treated with olanzapine: a case series.
Gilles M; Hentschel F; Paslakis G; Glahn V; Lederbogen F; Deuschle M
Clin Neuropharmacol; 2010; 33(5):248-9. PubMed ID: 20838214
[TBL] [Abstract][Full Text] [Related]
8. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
Deng C; Lian J; Pai N; Huang XF
J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
[TBL] [Abstract][Full Text] [Related]
9. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
Cooper GD; Harrold JA; Halford JC; Goudie AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80.
Richards M; Chiba S; Ninomiya M; Wakabayasi C; Kunugi H
Pharmacopsychiatry; 2013 Nov; 46(7):267-73. PubMed ID: 24105080
[TBL] [Abstract][Full Text] [Related]
11. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
Fell MJ; Marshall KM; Williams J; Neill JC
J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
[TBL] [Abstract][Full Text] [Related]
12. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
13. Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.
Lian J; Huang XF; Pai N; Deng C
Psychoneuroendocrinology; 2014 Oct; 48():77-86. PubMed ID: 24992721
[TBL] [Abstract][Full Text] [Related]
14. Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
Stefanidis A; Watt MJ; Cowley MA; Oldfield BJ
Neuropharmacology; 2017 Sep; 123():55-66. PubMed ID: 28400260
[TBL] [Abstract][Full Text] [Related]
15. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
Gothelf D; Falk B; Singer P; Kairi M; Phillip M; Zigel L; Poraz I; Frishman S; Constantini N; Zalsman G; Weizman A; Apter A
Am J Psychiatry; 2002 Jun; 159(6):1055-7. PubMed ID: 12042200
[TBL] [Abstract][Full Text] [Related]
16. Melatonin for prevention of metabolic side-effects of olanzapine in patients with first-episode schizophrenia: randomized double-blind placebo-controlled study.
Modabbernia A; Heidari P; Soleimani R; Sobhani A; Roshan ZA; Taslimi S; Ashrafi M; Modabbernia MJ
J Psychiatr Res; 2014 Jun; 53():133-40. PubMed ID: 24607293
[TBL] [Abstract][Full Text] [Related]
17. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
18. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
Coccurello R; Caprioli A; Ghirardi O; Conti R; Ciani B; Daniele S; Bartolomucci A; Moles A
Psychopharmacology (Berl); 2006 Jul; 186(4):561-71. PubMed ID: 16758241
[TBL] [Abstract][Full Text] [Related]
20. Profiling of energy metabolism in olanzapine-induced weight gain in rats and its prevention by the CB1-antagonist AVE1625.
Liebig M; Gossel M; Pratt J; Black M; Haschke G; Elvert R; Juretschke HP; Neumann-Haefelin C; Kramer W; Herling AW
Obesity (Silver Spring); 2010 Oct; 18(10):1952-8. PubMed ID: 20168311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
